Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05938270
Title A Study to Investigate the Biological Effects of AZD5305, Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. (ASCERTAIN)
Acronym ASCERTAIN
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | ESP | CAN | AUS

Facility Status City State Zip Country Details
Research Site RECRUITING Detroit Michigan 48202 United States Details
Research Site WITHDRAWN Saint Louis Missouri 63110 United States Details
Research Site RECRUITING Providence Rhode Island 02903 United States Details
Research Site RECRUITING Melbourne VIC 3000 Australia Details
Research Site RECRUITING South Brisbane 4101 Australia Details
Research Site RECRUITING Vancouver British Columbia V5Z 1M9 Canada Details
Research Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
Research Site RECRUITING Québec Quebec G1J 4Z1 Canada Details
Research Site RECRUITING Amsterdam 1066CX Netherlands Details
Research Site RECRUITING Nijmegen 6525 GA Netherlands Details
Research Site RECRUITING Barcelona 08036 Spain Details
Research Site RECRUITING Barcelona 8035 Spain Details
Research Site RECRUITING Madrid 28041 Spain Details
Research Site RECRUITING Valencia 46009 Spain Details
Research Site RECRUITING Cambridge CB2 0QQ United Kingdom Details
Research Site RECRUITING Manchester M20 4BX United Kingdom Details
Research Site RECRUITING Newcastle upon Tyne NE7 7AF United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field